ÂÜÀòÂÒÂ×

Prior to joining AltruBio Dr. Reed was a senior consultant at Genentech’s Pharma Technical Regulatory with the responsibilities in the global regulatory affairs of the marketed products lifecycle and portfolio management. Before that, Dr. Reed lead the Corporate Project Management and clinical operations at Tanvex BioPharma, and successfully directed several preclinical and clinical programs of the biosimilar products . Prior to that she was the regional commercial product launch manager at Teva/Allergan where she was responsible for the global product launch portfolio of over 100 generic products. Dr. Reed has commenced her career in the industry as a consultant at Washington Group International (London UK / Princeton NJ) where she managed number of projects for several global pharmaceutical companies, e.g. Grifols Los Angeles, CA, CSL Behring, Kankakee, IL, Bayer, Raleigh, NC, Gedeon Richter, Budapest, Hungary, Pfizer, Ringaskidy Ireland, Boehringer Ingelheim, Bracknell, UK. Dr. Reed received her PhD degree in Enzyme Histochemistry from the Institute of Experimental Medicine, Czech Academy of Science in Prague, Czechia.